Columbia University

Technology Ventures

Latest News

Sapience Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics to address difficult to treat oncology indications, announced that it has raised $22.5 million in a Series A financing.
Columbia University is among the Top 100 Worldwide Universities Granted U.S. Utility Patents Ranking for 2015.
VidRovr, an innovative video management and processing platform developed by PhD students in Columbia Engineering’s Digital and Multimedia Lab, has been named among the Publicis90, a select group of start-ups that will receive funding and a year of guidance from executive mentors at Publicis Groupe.
The consortium aligns four major academic institutions in a unified partnership with the shared goal of creating high-impact research programs to discover new treatments for cancer.
By dynamically adjusting a VR user's field of view, the researchers say they've developed a method to reduce motion sickness without sacrificing a sense of presence.
Columbia Engineering Professor Steven K. Feiner and Ajoy Fernandes MS’16 have developed a method of combating virtual reality (VR) sickness that can be applied to consumer head-worn VR displays, such as the Oculus Rift, HTC Vive, Sony PlayStation VR, and Google Cardboard.
The Rio Olympics do not begin until August, but we already know one thing about the winners—their average age will be around 26, at least for endurance athletes like swimmers and runners.
Scientists from the Center for Radiological Research at Columbia University Medical Center have shown that a narrow wavelength of ultraviolet (UV) light safely killed drug-resistant MRSA bacteria in mice, demonstrating a potentially safe and cost-effective way to reduce surgical site infections.
A new study reports on the results of a randomized clinical trial that looked at whether the antidepressant citalopram would enhance complicated grief treatment psychotherapy, and if citalopram would be efficacious without it.